BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17430154)

  • 1. Drug resistance in childhood acute myeloid leukemia.
    Styczynski J
    Curr Pharm Biotechnol; 2007 Apr; 8(2):59-75. PubMed ID: 17430154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo drug resistance in childhood acute myeloid leukemia on relapse is not higher than at first diagnosis.
    Styczynski J; Wysocki M
    Pediatr Blood Cancer; 2004 Feb; 42(2):195-9. PubMed ID: 14752887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
    Willman CL
    Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.
    Meshinchi S; Smith FO; Arceci RJ
    Curr Oncol Rep; 2003 Nov; 5(6):489-97. PubMed ID: 14521808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia.
    Styczynski J; Wysocki M; Debski R; Czyzewski K; Kolodziej B; Rafinska B; Kubicka M; Koltan S; Koltan A; Pogorzala M; Kurylak A; Olszewska-Slonina D; Balwierz W; Juraszewska E; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Malinowska I; Stanczak E; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Maciejka-Kapuscinska L
    J Cancer Res Clin Oncol; 2007 Nov; 133(11):875-93. PubMed ID: 17671794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemia.
    Styczynski J; Wysocki M; Debski R; Juraszewska E; Malinowska I; Stanczak E; Ploszynska A; Stefaniak J; Mazur B; Szczepanski T
    Leuk Lymphoma; 2002 Sep; 43(9):1843-8. PubMed ID: 12685842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic scoring model based on multi-drug resistance status and cytogenetics in adult patients with acute myeloid leukemia.
    Kim DH; Lee NY; Baek JH; Kim JG; Sohn SK; Suh JS; Lee KS; Lee KB
    Leuk Lymphoma; 2006 Mar; 47(3):461-7. PubMed ID: 16396769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.
    Benderra Z; Faussat AM; Sayada L; Perrot JY; Chaoui D; Marie JP; Legrand O
    Clin Cancer Res; 2004 Dec; 10(23):7896-902. PubMed ID: 15585622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte-macrophage colony-stimulating factor receptor-targeted therapy of chemotherapy- and radiation-resistant human myeloid leukemias.
    Perentesis JP; Bendel AE; Shao Y; Warman B; Davies SM; Yang CH; Chandan-Langlie M; Waddick KG; Uckun FM
    Leuk Lymphoma; 1997 Apr; 25(3-4):247-56. PubMed ID: 9168435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytogenetics and in vitro drug resistance of acute leukemia in children and adults].
    Styczyński J; Haus O
    Postepy Hig Med Dosw (Online); 2006; 60():527-37. PubMed ID: 17060894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer resistance protein in drug resistance of primitive CD34+38- cells in acute myeloid leukemia.
    Raaijmakers MH; de Grouw EP; Heuver LH; van der Reijden BA; Jansen JH; Scheper RJ; Scheffer GL; de Witte TJ; Raymakers RA
    Clin Cancer Res; 2005 Mar; 11(6):2436-44. PubMed ID: 15788695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative study.
    Kaspers GJ; Zwaan CM; Veerman AJ; Rots MG; Pieters R; Bucsky P; Domula M; Göbel U; Graf N; Havers W; Jorch N; Kabisch K; Spaar HJ; Ritter J; Creutzig U
    Klin Padiatr; 1999; 211(4):239-44. PubMed ID: 10472557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia.
    List AF
    Leukemia; 1996 Apr; 10 Suppl 1():S36-8. PubMed ID: 8618469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal aberrations in 17p predict in vitro drug resistance and short overall survival in acute myeloid leukemia.
    Nahi H; Lehmann S; Bengtzen S; Jansson M; Möllgård L; Paul C; Merup M
    Leuk Lymphoma; 2008 Mar; 49(3):508-16. PubMed ID: 18297528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias.
    Fazlina N; Maha A; Jamal R; Zarina AL; Cheong SK; Hamidah H; Ainoon O; Zulkifli SZ; Hamidah NH
    Hematology; 2007 Feb; 12(1):33-7. PubMed ID: 17364990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine, treosulfan and etoposide sensitivity and the outcome of hematopoietic stem cell transplantation in childhood acute myeloid leukemia.
    Styczynski J; Toporski J; Wysocki M; Debski R; Chybicka A; Boruczkowski D; Wachowiak J; Wojcik B; Kowalczyk J; Gil L; Balwierz W; Matysiak M; Krawczuk-Rybak M; Balcerska A; Sonta-Jakimczyk D
    Anticancer Res; 2007; 27(3B):1547-51. PubMed ID: 17595774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.
    Styczynski J; Wysocki M; Debski R; Czyzewski K; Balwierz W; Juraszewska E; Matysiak M; Malinowska I; Stanczak E; Sońta-Jakimczyk D; Szczepanski T; Wachowiak J; Konatkowska B; Balcerska A; Ploszynska A; Kowalczyk J; Stefaniak J; Badowska W; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M
    Neoplasma; 2005; 52(1):74-8. PubMed ID: 15739031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemia.
    van der Pol MA; Broxterman HJ; Pater JM; Feller N; van der Maas M; Weijers GW; Scheffer GL; Allen JD; Scheper RJ; van Loevezijn A; Ossenkoppele GJ; Schuurhuis GJ
    Haematologica; 2003 Feb; 88(2):134-47. PubMed ID: 12604403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular drug resistance in childhood acute myeloid leukemia. A mini-review with emphasis on cell culture assays.
    Kaspers GJ; Zwaan CM; Pieters R; Veerman AJ
    Adv Exp Med Biol; 1999; 457():415-21. PubMed ID: 10500817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?
    Broxterman HJ; Sonneveld P; Pieters R; Lankelma J; Eekman CA; Loonen AH; Schoester M; Ossenkoppele GJ; Löwenberg B; Pinedo HM; Schuurhuis GJ
    Leukemia; 1999 Feb; 13(2):258-65. PubMed ID: 10025900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.